0

Journal Articles

in Prostate Cancer
 1-20 of 100 Articles
Original Contribution |  November 14, 2012 FREE
Multivitamins in the Prevention of Cancer in Men:  The Physicians' Health Study II Randomized Controlled Trial
J. Michael Gaziano, MD, MPH; Howard D. Sesso, ScD, MPH; William G. Christen, ScD; et al.
JAMA. 2012;308(18):1871-1880. doi:10.1001/jama.2012.14641.
INCLUDES: CME , Supplemental Content
Medical News and Perspectives |  August 01, 2012
New Research Reveals Positive Therapies and Methods for Treating Prostate Cancer
Mike Mitka
JAMA. 2012;308(5):441-442. doi:10.1001/jama.2012.7960.
Research Letters |  April 25, 2012 FREE
2008 US Preventive Services Task Force Recommendations and Prostate Cancer Screening Rates
Sandip M. Prasad, MD, MPhil; Michael W. Drazer, BA; Dezheng Huo, MD, PhD; et al.
JAMA. 2012;307(16):1692-1694. doi:10.1001/jama.2012.534.
Original Contribution |  April 18, 2012 FREE
Intensity-Modulated Radiation Therapy, Proton Therapy, or Conformal Radiation Therapy and Morbidity and Disease Control in Localized Prostate Cancer
Nathan C. Sheets, MD; Gregg H. Goldin, MD; Anne-Marie Meyer, PhD; et al.
JAMA. 2012;307(15):1611-1620. doi:10.1001/jama.2012.460.
INCLUDES: , Supplemental Content
Viewpoint |  February 08, 2012
The Harms of Screening:  New Attention to an Old Concern
Steven H. Woolf, MD, MPH; Russell Harris, MD, MPH
JAMA. 2012;307(6):565-566. doi:10.1001/jama.2012.100.
Medical News and Perspectives |  January 11, 2012
Expert Panel Advocates Surveillance for Men With Low-Risk Prostate Cancer
Anita Slomski
JAMA. 2012;307(2):133. doi:10.1001/jama.2011.1965.
Commentary |  December 28, 2011
Prostate Cancer Screening—Time to Abandon One-Size-Fits-All Approach?
Jeri Kim, MD; John W. Davis, MD
JAMA. 2011;306(24):2717-2718. doi:10.1001/jama.2011.1881.
Commentary |  December 28, 2011
Missing the Mark on Prostate-Specific Antigen Screening
David C. Miller, MD, MPH; Brent K. Hollenbeck, MD, MS
JAMA. 2011;306(24):2719-2720. doi:10.1001/jama.2011.1879.
Commentary |  December 28, 2011
Grading the New US Preventive Services Task Force Prostate Cancer Screening Recommendation
Robert J. Volk, PhD; Andrew M. D. Wolf, MD
JAMA. 2011;306(24):2715-2716. doi:10.1001/jama.2011.1893.
Commentary |  December 28, 2011
Prostate Cancer Screening—The Evidence, the Recommendations, and the Clinical Implications
Roger Chou, MD; Michael L. LeFevre, MD, MSPH
JAMA. 2011;306(24):2721-2722. doi:10.1001/jama.2011.1891.
Editorial |  December 07, 2011
Androgen Deprivation Therapy and Competing Risks
William K. Kelly, DO; Leonard G. Gomella, MD
JAMA. 2011;306(21):2382-2383. doi:10.1001/jama.2011.1791.
Review |  December 07, 2011 FREE
Association of Androgen Deprivation Therapy With Cardiovascular Death in Patients With Prostate Cancer:  A Meta-analysis of Randomized Trials
Paul L. Nguyen, MD; Youjin Je, MS; Fabio A. B. Schutz, MD; et al.
JAMA. 2011;306(21):2359-2366. doi:10.1001/jama.2011.1745.
Original Contribution |  October 12, 2011 FREE
Vitamin E and the Risk of Prostate Cancer:  The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Eric A. Klein, MD; Ian M. Thompson, MD; Catherine M. Tangen, DrPH; et al.
JAMA. 2011;306(14):1549-1556. doi:10.1001/jama.2011.1437.
Lab Reports |  October 05, 2011
Lethal Prostate Cancer Variants
Tracy Hampton, PhD
JAMA. 2011;306(13):1431. doi:10.1001/jama.2011.1389.
Original Contribution |  September 21, 2011 FREE
Prediction of Erectile Function Following Treatment for Prostate Cancer
Mehrdad Alemozaffar, MD; Meredith M. Regan, ScD; Matthew R. Cooperberg, MD, MPH; et al.
JAMA. 2011;306(11):1205-1214. doi:10.1001/jama.2011.1333.
INCLUDES: , Supplemental Content
Original Contribution |  June 22, 2011 FREE
Smoking and Prostate Cancer Survival and Recurrence
Stacey A. Kenfield, ScD; Meir J. Stampfer, MD, DrPH; June M. Chan, ScD; et al.
JAMA. 2011;305(24):2548-2555. doi:10.1001/jama.2011.879.
Medical News & Perspectives |  June 08, 2011
Debate Continues on Use of PSA Testing for Early Detection of Prostate Cancer
M. J. Friedrich
JAMA. 2011;305(22):2273-2276. doi:10.1001/jama.2011.777.
Medical News & Perspectives |  April 20, 2011
Experts Debate Utility of PSA Velocity as a Criterion for Prostate Biopsy
Mike Mitka
JAMA. 2011;305(15):1522. doi:10.1001/jama.2011.492.
Health Agencies Update |  December 22, 2010
Prostate Drug Warnings
Bridget M. Kuehn
JAMA. 2010;304(24):2687. doi:10.1001/jama.2010.1815.
Editorial |  December 01, 2010
Active Surveillance for Prostate Cancer
Ian M. Thompson, MD; Laurence Klotz, MD
JAMA. 2010;304(21):2411-2412. doi:10.1001/jama.2010.1761.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Original Investigation  |  Mar 11, 2013
Comparing 3 Techniques for Eliciting Patient Values for Decision Making About Prostate-Specific Antigen Screening:  A Randomized Controlled Trial
Michael Patrick Pignone, MD, MPH; Kirsten Howard, PhD, MPH; Alison Tytell Brenner, MPH; et al.
JAMA Internal Medicine
Invited Commentary  |  Mar 11, 2013
Bridging the Gap at the Center of Patient Centeredness: Individual Patient Preferences in Health Care Decision Making:  Comment on “Comparing 3 Techniques for Eliciting Patient Values for Decision Making About Prostate-Specific Antigen Screening”
Sara J. Knight, PhD
JAMA Internal Medicine
In This Issue of JAMA Internal Medicine  |  Mar 11, 2013
In This Issue of JAMA Internal Medicine
JAMA Internal Medicine
Editor's Correspondence  |  Mar 11, 2013
Prostate-Specific Antigen for Prostate Cancer Screening: A Different Strategy Should Be Planned
Giuseppe Lippi, MD; Camilla Mattiuzzi, MD; Gianfranco Cervellin, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems